Citigroup’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1K | Sell |
2,135
-585
| -22% | -$4.68K | ﹤0.01% | 4380 |
|
|
2025
Q1 | $26.6K | Sell |
2,720
-247
| -8% | -$2.41K | ﹤0.01% | 4265 |
|
|
2024
Q4 | $37.5K | Buy |
2,967
+146
| +5% | +$1.85K | ﹤0.01% | 4303 |
|
|
2024
Q3 | $45.4K | Buy |
2,821
+906
| +47% | +$14.6K | ﹤0.01% | 4265 |
|
|
2024
Q2 | $46.7K | Buy |
1,915
+1,257
| +191% | +$30.7K | ﹤0.01% | 3890 |
|
|
2024
Q1 | $47.2K | Sell |
658
-4,241
| -87% | -$304K | ﹤0.01% | 3915 |
|
|
2023
Q4 | $974K | Sell |
4,899
-309
| -6% | -$61.4K | ﹤0.01% | 2170 |
|
|
2023
Q3 | $692K | Sell |
5,208
-362
| -6% | -$48.1K | ﹤0.01% | 2168 |
|
|
2023
Q2 | $833K | Sell |
5,570
-8,320
| -60% | -$1.24M | ﹤0.01% | 2370 |
|
|
2023
Q1 | $2.04M | Buy |
13,890
+3,139
| +29% | +$461K | ﹤0.01% | 1529 |
|
|
2022
Q4 | $1.7M | Buy |
10,751
+2,557
| +31% | +$405K | ﹤0.01% | 1634 |
|
|
2022
Q3 | $1.58M | Buy |
8,194
+3,860
| +89% | +$743K | ﹤0.01% | 1769 |
|
|
2022
Q2 | $633K | Buy |
4,334
+2,510
| +138% | +$367K | ﹤0.01% | 2425 |
|
|
2022
Q1 | $321K | Sell |
1,824
-6,766
| -79% | -$1.19M | ﹤0.01% | 3129 |
|
|
2021
Q4 | $2.52M | Buy |
8,590
+8,053
| +1,500% | +$2.37M | ﹤0.01% | 1800 |
|
|
2021
Q3 | $133K | Buy |
537
+198
| +58% | +$49K | ﹤0.01% | 3567 |
|
|
2021
Q2 | $86K | Buy |
339
+169
| +99% | +$42.9K | ﹤0.01% | 3909 |
|
|
2021
Q1 | $30K | Sell |
170
-269
| -61% | -$47.5K | ﹤0.01% | 4346 |
|
|
2020
Q4 | $69K | Buy |
439
+373
| +565% | +$58.6K | ﹤0.01% | 3910 |
|
|
2020
Q3 | $17K | Sell |
66
-120
| -65% | -$30.9K | ﹤0.01% | 4047 |
|
|
2020
Q2 | $43K | Buy |
186
+134
| +258% | +$31K | ﹤0.01% | 3848 |
|
|
2020
Q1 | $9K | Buy |
52
+13
| +33% | +$2.25K | ﹤0.01% | 4664 |
|
|
2019
Q4 | $8K | Buy |
+39
| New | +$8K | ﹤0.01% | 4768 |
|